Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration.
behavior change
cancer specialists
implementation science
primary care
quality
survivorship
theoretical domains framework (TDF)
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
10
12
2018
revised:
05
03
2019
accepted:
05
03
2019
pubmed:
6
4
2019
medline:
11
6
2020
entrez:
6
4
2019
Statut:
ppublish
Résumé
With over 3 million US prostate cancer survivors, ensuring high-quality, coordinated cancer survivorship care is important. However, implementation of recommended team-based cancer care has lagged, and determinants of quality care across primary and specialty care remain unclear. Guided by the theoretical domains framework (TDF), we explored multidisciplinary determinants of quality survivorship care in an integrated delivery system. We conducted semistructured interviews with primary (4) and specialty (7) care providers across 6 Veterans Health Administration clinic sites. Using template analysis, we coded interview transcripts into the TDF, mapping statements to specific constructs within each domain. We assessed whether each construct was perceived a barrier or facilitator, examining results for both primary care providers (PCPs) and prostate cancer specialists. Cancer specialists and PCPs identified 2 primary TDF domains impacting their prostate cancer survivorship care: Knowledge and Environmental context and resources. Both groups noted knowledge (about survivorship care) and procedural knowledge (about how to deliver survivorship care) as positive determinants or facilitators, whereas resources/material resources (to deliver survivorship care) was noted as a negative determinant or barrier to care. Additional domains more commonly referenced by cancer specialists included Social/professional role and identity and Goals, while PCPs reported the domain Beliefs about capabilities as relevant. We used the TDF to identify several behavioral domains acting as determinants of high-quality, team-based prostate cancer survivorship care. These results can inform prostate cancer survivorship care plan content, and may guide tailored, multidisciplinary implementation strategies to improve survivorship care across the primary and specialty care interface.
Sections du résumé
BACKGROUND
With over 3 million US prostate cancer survivors, ensuring high-quality, coordinated cancer survivorship care is important. However, implementation of recommended team-based cancer care has lagged, and determinants of quality care across primary and specialty care remain unclear. Guided by the theoretical domains framework (TDF), we explored multidisciplinary determinants of quality survivorship care in an integrated delivery system.
METHODS
We conducted semistructured interviews with primary (4) and specialty (7) care providers across 6 Veterans Health Administration clinic sites. Using template analysis, we coded interview transcripts into the TDF, mapping statements to specific constructs within each domain. We assessed whether each construct was perceived a barrier or facilitator, examining results for both primary care providers (PCPs) and prostate cancer specialists.
RESULTS
Cancer specialists and PCPs identified 2 primary TDF domains impacting their prostate cancer survivorship care: Knowledge and Environmental context and resources. Both groups noted knowledge (about survivorship care) and procedural knowledge (about how to deliver survivorship care) as positive determinants or facilitators, whereas resources/material resources (to deliver survivorship care) was noted as a negative determinant or barrier to care. Additional domains more commonly referenced by cancer specialists included Social/professional role and identity and Goals, while PCPs reported the domain Beliefs about capabilities as relevant.
CONCLUSIONS
We used the TDF to identify several behavioral domains acting as determinants of high-quality, team-based prostate cancer survivorship care. These results can inform prostate cancer survivorship care plan content, and may guide tailored, multidisciplinary implementation strategies to improve survivorship care across the primary and specialty care interface.
Identifiants
pubmed: 30950216
doi: 10.1002/cam4.2106
pmc: PMC6536973
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2686-2702Subventions
Organisme : NCI NIH HHS
ID : R37 CA222885
Pays : United States
Informations de copyright
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
CA Cancer J Clin. 2014 Jul-Aug;64(4):225-49
pubmed: 24916760
CA Cancer J Clin. 2013 May;63(3):147-50
pubmed: 23512728
Cancer. 2012 Jun 1;118(11):2837-45
pubmed: 22370955
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
JAMA Intern Med. 2017 Dec 1;177(12):1726-1732
pubmed: 28973067
N Engl J Med. 2016 Oct 13;375(15):1425-1437
pubmed: 27626365
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
J Natl Cancer Inst Monogr. 2010;2010(40):25-30
pubmed: 20386051
J Cancer Surviv. 2013 Sep;7(3):343-54
pubmed: 23526165
Implement Sci. 2014 Nov 15;9:167
pubmed: 25398477
J Oncol Pract. 2007 Mar;3(2):79-86
pubmed: 20859376
Cancer. 2015 Apr 1;121(7):978-96
pubmed: 25252164
J Clin Oncol. 2016 Nov 10;34(32):3834-3837
pubmed: 27621409
Ann Surg. 2018 Mar;267(3):432-434
pubmed: 28902665
Cancer Med. 2019 May;8(5):2686-2702
pubmed: 30950216
Br J Gen Pract. 2009 Jul;59(564):e248-59
pubmed: 19566991
Lancet Oncol. 2017 Jan;18(1):e30-e38
pubmed: 28049575
Fed Pract. 2014 Aug;31(8):10-17
pubmed: 30369784
J Oncol Pract. 2014 Mar;10(2):e81-5
pubmed: 24065401
J Urol. 2010 Dec;184(6):2279-84
pubmed: 20952017
J Natl Compr Canc Netw. 2017 Sep;15(9):1165-1169
pubmed: 28874600
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
J Gen Intern Med. 2011 Dec;26(12):1403-10
pubmed: 21785923
Br J Cancer. 2014 Nov 11;111(10):1899-908
pubmed: 25314068
Urol Oncol. 2013 Aug;31(6):727-32
pubmed: 21775171